Paper Details

  1. Home
  2. Paper Details

Use of atropine-diphenoxylate compared with hyoscyamine to decrease rates of irinotecan-related cholinergic syndrome.

Author: ChengConnie, EarlMarc A, LauJessica E

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study compared the efficacy of atropine-diphenoxylate and hyoscyamine as premedications for prophylaxis of cholinergic syndrome associated with irinotecan infusion.
Paper Details　
Original Abstract of the Article :
Cholinergic syndrome is a well established acute adverse reaction associated with irinotecan. Cholinergic side effects can be ameliorated or prevented with anticholinergic agents. To date, no formal studies have compared atropine-diphenoxylate and hyoscyamine as premedications for prophylaxis of the...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.12788/jcso.0099

データ提供：米国国立医学図書館（NLM）

Navigating the Side Effects of Cancer Treatment

Cancer treatment, like a challenging trek through the desert, can bring about various side effects. This study focuses on cholinergic syndrome, a common side effect of the drug irinotecan, used to treat certain types of cancer. This syndrome can cause unpleasant symptoms, making the journey even more difficult. The researchers set out to compare the effectiveness of two different medications, atropine-diphenoxylate and hyoscyamine, in preventing or reducing these symptoms. They found that both medications were effective, but a formal comparison is still needed to determine the best option for patients.

Finding Relief from Side Effects

The study sheds light on the potential of anticholinergic agents in managing cholinergic syndrome associated with irinotecan treatment. This could potentially improve the quality of life for patients undergoing this challenging therapy. The research underscores the need for further investigation to determine the optimal medication for individual patients. This could lead to more personalized treatment plans and improved outcomes for those navigating the often-difficult landscape of cancer treatment.

Facing Challenges with Strength

Facing cancer, like traversing a vast desert, takes strength and resilience. This study underscores the importance of finding ways to manage the side effects of treatment and improve the overall patient experience. By understanding the potential of different medications and working closely with their healthcare providers, patients can face these challenges with strength and hope.

Dr.Camel's Conclusion

This study offers a glimpse into the world of cancer treatment, a journey that requires a careful balance of therapies and support. Understanding and managing side effects, like finding an oasis in the desert, can make this journey more manageable. By continuing to explore the potential of different medications and approaches, we can help improve the lives of those facing this challenge.

Date :
  1. Date Completed 2016-07-02
  2. Date Revised 2015-04-03
Further Info :

Pubmed ID

25839059

DOI: Digital Object Identifier

10.12788/jcso.0099

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.